Chemoinformaics analysis of 7-HYDROXY-6-METHOXY-3-(2-OXOCHROMEN-7-YL)OXYCHROMEN-2-ONE
Molecular Weight | 352.298 | nRot | 3 |
Heavy Atom Molecular Weight | 340.202 | nRig | 24 |
Exact Molecular Weight | 352.058 | nRing | 4 |
Solubility: LogS | -4.555 | nHRing | 2 |
Solubility: LogP | 2.61 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 4 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 38 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 26 | No. of Aromatic Carbocycles | 2 |
nHetero | 7 | No. of Aromatic Hetero Cycles | 2 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 19 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 20 |
No. of Oxygen atom | 7 | No. of Arom Bond | 22 |
nHA | 7 | APOL | 45.3455 |
nHD | 1 | BPOL | 20.7185 |
QED | 0.564 |
Synth | 2.476 |
Natural Product Likeliness | 0.723 |
NR-PPAR-gamma | 0.56 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.231 |
Pgp-sub | 0.031 |
HIA | 0.011 |
CACO-2 | -4.868 |
MDCK | 0.0000498 |
BBB | 0.018 |
PPB | 0.915599 |
VDSS | 0.402 |
FU | 0.0751403 |
CYP1A2-inh | 0.931 |
CYP1A2-sub | 0.92 |
CYP2c19-inh | 0.616 |
CYP2c19-sub | 0.059 |
CYP2c9-inh | 0.545 |
CYP2c9-sub | 0.908 |
CYP2d6-inh | 0.5 |
CYP2d6-sub | 0.893 |
CYP3a4-inh | 0.669 |
CYP3a4-sub | 0.247 |
CL | 7.979 |
T12 | 0.732 |
hERG | 0.109 |
Ames | 0.026 |
ROA | 0.573 |
SkinSen | 0.414 |
Carcinogencity | 0.778 |
EI | 0.697 |
Respiratory | 0.155 |
NR-Aromatase | 0.842 |
Antiviral | Yes |
Prediction | 0.796351 |